|
oestrogen and progesterone receptors |
||||||||||||||
low MW |
high MW |
||||||||||||||
17/172 |
10/172 |
+ |
- |
4/172 |
+ |
|
17/172 |
|
4/172 |
|
|
- |
|
|
|
endocervical-type mucinous tumours |
|
|
+ |
- |
+ |
|
|
|
|
|
|
- |
|
+ |
|
intestinal type mucinous tumours |
|
|
+ |
+ |
+ |
|
|
|
|
|
|
- |
|
- |
|
endometrioid tumours |
|
|
|
|
|
+ |
|
|
|
|
|
|
- |
|
|
Brenner tumours |
|
|
+ |
- |
+ |
+ |
+ |
|
|
|
|
|
- |
|
|
granulosa cell tumours |
|
|
|
|
|
|
100%4 |
50%4 |
90%4 |
- |
+ |
90% |
PR +ve3, ER -ve3 |
||
juvenile granulosa cell tumours |
~50% |
|
|
|
- |
|
|
|
+ |
|
|
|
+ |
|
|
Sertoli(-Leydig) cell tumour |
50%4 |
|
|
|
|
- |
|
|
100%4 |
100%4 |
|
|
+ |
var |
|
Leydig cell tumour |
neg4 |
|
|
|
|
|
|
|
pos4 |
|
|
|
|
|
|
- |
|
|
|
|
|
|
|
+ |
|
|
|
+ |
|
|
|
steroid cell tumours |
30-50% |
|
|
|
|
|
|
|
+ |
|
30% |
|
+ |
|
|
+ |
|
|
|
|
30-75% |
|
|
+ |
|
|
|
- |
|
|
See also: Melan-A (A103) immunostaining in ovarian sex cord stromal tumours.
One case of thyroglobulin-positivity in a series of 17 papillary serous carcinomas has been reported2.
Differential diagnoses
Sex cord stromal tumour versus sertoliform endometrioid carcinoma: inhibin and EMA (or CK 7) appear most useful. Beware of inhibin positivity in reactive stromal cells associated with carcinomas; this occurs most frequently in association with mucinous carcinomas8.
|
SCST |
endometrioid carcinoma |
broad spectrum anti-cytokeratins |
positive, except pure Leydig cell tumours |
positive |
negative, except for Retiform areas of Sertoli-Leydig cell tumours5 |
positive, including 5/6 sex cord-like endometrioid carcinomas5 |
|
90% of granulosa cell tumours, variably in Sertoli-Leydig cell tumours6 |
positive in some sex cord-like endometrioid carcinoma (but not membranous staining)6 |
|
positive ( vide supra ) |
negative |
|
negative |
usually positive, but may only be focal7 |
|
Sex cord stromal tumour versus sarcoma: the possible sarcomas include haemangiopericytoma, leiomyosarcoma and endometrial stromal sarcoma. This may particularly be a problem with late recurrences of granulosa cell tumour. The sarcomas are negative for inhibin. Endometrial stromal sarcoma is positive for CD10. When endometrial stroma sarcoma has sex cord-like elements, these structures are usually positive for a-inhibin. Calretinin may be helpful in inhibin-negative sarcomatous sex cord stromal tumours. Luteinised granulosa cell tumour may resemble an epithelioid smooth muscle tumour and may be positive for smooth muscle actin. Luteinised granulosa cell tumours are reliably positive for a-inhibin. whereas inhibin positivity has not been reported in smooth muscle tumours.
Granulosa cell tumour versus yolk sac tumour. Hepatoid yolk sac tumour may resemble juvenile granulosa cell tumour, which may also show minor foci of hepatoid differentiation. Foci of syncytiotrophoblast in mixed germ cells tumours are likely to be intensely positive for a-inhibin.
Hypercalcaemic type small cell carcinoma may particularly resemble juvenile granulosa cell tumour but cells have less cytoplasm in the former. Both may have a high mitotic rate.
|
granulosa cell tumour |
hypercalcaemic small cell carcinoma |
yolk sac tumour |
a-inhibin |
positive |
negative |
negative; may be focally positive in hepatoid yolk sac tumour |
positive |
positive |
negative |
|
negative |
negative |
positive |
|
a-antitypsin |
negative |
negative |
positive |
negative |
negative |
positive |
|
Metastatic adenocarcinomas of colon or breast may mimic primitive sex cord stromal tumours. a-inhibin may be focally and weakly positivity. The rare benign signet ring stromal tumour resembles signet ring cell carcinoma (Krukenberg tumour).
|
signet-ring stromal tumour |
Krukenberg tumour |
|
a-inhibin |
positive |
||
negative |
positive |
||
positive |
negative |
||
negative |
positive |
||
negative |
positive |
||
Oxyphilic tumours. The following tumours may all appear oxyphilic:
metastatic renal cell carcinoma
References
Diagnostic histopathology of tumors. Edited by CDM Fletcher. 2nd edition. Churchill Livingstone. Pages 567-625.
This page last revised 3.9.2001.